08/28/2026
🎥 Watch Mauricio Co**ha, MD, explain how blood-based biomarkers, especially P-tau217, are revolutionizing Alzheimer’s diagnosis! These tests enable rapid, accurate, and accessible detection for cognitively impaired patients, streamline workflows, boost diagnostic confidence, and guide early treatment decisions—all while preserving the role of confirmatory testing when needed. Stay informed on the future of Alzheimer’s care! ▶ https://tinyurl.com/5y7feuj2